4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001209191-23-024386
Prin. Fin. and Acctg. Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Donegan Michael C Prin. Fin. and Acctg. Officer | 2023-04-12 | Option exercise | +50,000 | 61,853 | D | ||
| Derivatives | |||||||
| Donegan Michael C Prin. Fin. and Acctg. Officer | 2023-04-12 | Option exercise · Restricted Stock Units | −50,000 | 0 | D | ||
Loading xslF345X04/doc4.xml…